Navigation Links
Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Date:8/23/2007

BOCA RATON, Fla., Aug. 23 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals (Nasdaq: NABI) today announced that Dr. Leslie Hudson, interim president and chief executive officer will participate in the Thomas Weisel Partners Healthcare Conference, to be held Sept. 5-7, 2007 at The Four Seasons Hotel in Boston. Dr. Hudson's presentation at the conference is scheduled for Thursday, Sept. 6 at 2:05 p.m. EDT. Dr. Hudson is also scheduled to participate in the Bear Stearns Healthcare Conference, to be held Sept. 10-11, 2007 at The Grand Hyatt Hotel in New York, where he is slated to present on Tuesday, Sept. 11 at 2:30 p.m. EDT.

At both conferences, Dr. Hudson will present a company overview including a review of Nabi's corporate strategy and an update of its clinical development programs. Webcasts of these presentations and webcast information can be accessed on the company's "Events and Webcasts" page at http://www.nabi.com.

About Nabi Biopharmaceuticals

Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and, in certain areas, market products that target serious medical conditions in the areas of hepatitis and transplants, gram positive bacterial infections and nicotine addiction. We are a vertically integrated company with sales of antibodies and other biologics, including Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], a pipeline of products in various stages of development, state-of-the-art manufacturing capability and a cash position that will allow us to advance our near-term pipeline products. The company operates through two strategic business units: Nabi Biologics and Nabi Pharmaceuticals. Nabi
'/>"/>

SOURCE Nabi Biopharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ov. 19 Omeros Corporatio...cial results for the third quarter ended September..., 2009, Omeros reported a net loss of $3.9 million... $7.4 million, or $2.54 per share, for the same pe...30, 2009, the Company reported a net loss of $15.5...
(Date:11/19/2009)...N, Pa. and WALTHAM, Mass., Nov. 19 ...sources find that the leading driver of antibiotic...oad-spectrum activity against gram-positive and gr...isms that can cause nosocomial pneumonia, surveyed...ly for agents that provide appropriate coverage ag...
(Date:11/19/2009)... InSound is honored by latest award for revolu...wark, CA (PRWEB) November 16, 2009 -- Popular Scie...rdquo; hearing aid from InSound Medical a winner o...e Health category.    Chosen f...side deep in the hearing canal for up to four mont...
(Date:11/18/2009)...Imagine a polka-dotted postage stamp that can snif...hanging colors. , As reported in the Sept. 13 is...lick and his team at the University of Illinois ha...tection of toxic industrial chemicals (TICs) that ...alizing odors. This sensor array could be useful ...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3
... Cell Product Candidate Enters Clinical Trials, R...ls, a,clinical-stage company developing novel anti...oday announced the successful completion of the fi...ng $93 million. This tranche,brings the total Seri...a,Phase4 Ventures participated in the financing al...
... Wall St. Network,s 3-Minute,Press Show is a dail...that,features in-depth interviews with public comp...ess releases., The show is designed to provide vi...nd its impact on the company,s growth., Shows ...et/3-min-press/3-min-press.php , The following ex...
... Rising concerns over food and water saf...sting contaminants thereby generating strong deman...Market size projections look bright with the 2012 ...he largest market for agricultural and environment...ents the largest and fastest growth segment. , ...
Other Biology Technology:OncoMed Pharmaceuticals Completes Series B Financing 2OncoMed Pharmaceuticals Completes Series B Financing 3[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR, BHRT, AGO 2Global Agricultural and Environmental Diagnostics Market to Reach $2.4 Billion by 2012, According to New Report by Global Industry Analysts 2Global Agricultural and Environmental Diagnostics Market to Reach $2.4 Billion by 2012, According to New Report by Global Industry Analysts 3
(Date:11/19/2009)...tainable farming, initially adopted to preserve so... role in maintaining a healthy climate, according ...idge and Los Alamos national laboratories. , ORN...ntial of the earth,s soils to sequester carbon, wi...could greatly reduce U.S. carbon emissions by as m...
(Date:11/19/2009)...ti professor of paleontology in the McMicken Colle... of the University of Chicago publish their resear...per, "Epicontinental Seas Versus Open-Ocean Settin...n." , For many years, paleobiological researcher...ocused on charting the many ups (evolutionary radi...
(Date:11/19/2009)...te professor in the Fischell Department of Bioengi...ioscience Research and Technology Review Day with ...bone and other types of tissue for implantation. ,...presented in an eight minute pitch by faculty memb... Fair, held November 12 at the University of Maryl...
Breaking Biology News(10 mins):ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Green Bridge Industries Inc to Exhibit ZAP 28TM 29 Stain Remover Pen at the L A County Fair 56267 1Green Bridge Industries Inc to Exhibit ZAP 28TM 29 Stain Remover Pen at the L A County Fair 56267 2Surgical scrub solution 3A Its good for patients too 56263 1Surgical scrub solution 3A Its good for patients too 56263 2Surgical scrub solution 3A Its good for patients too 56263 3Surgical scrub solution 3A Its good for patients too 56263 4GENova names Dr John Savin as Vice President 56261 1GENova names Dr John Savin as Vice President 56261 2
...UC) suggests that the widely abused club drug "ecs...ine cells in the brain during fetal development. ...ion of voluntary movement, the findings, the resea...logical diseases like Parkinson,s. , Led by Jack...as presented today as an abstract at the Society f...
...species of green algae that practice different for...ight on one route by which evolution gave rise to ...and egg cells. The findings, which indicate that a...uction was likely co-opted during evolution to par...ported by Hisayoshi Nozaki and colleagues at the U...
... be triggered in the thymus, where the immune syst... just one of the body,s thousands of proteins as "...t autoimmunity can start in this cradle of the imm...mune diseases emerge, such as the pancreas in the ...id arthritis. , The discovery, from a mouse model...
Other Biology News:Research links 'ecstasy' to survival of key movement-related cells in brain 2A new male-specific gene in algae unveils an origin of male and female 2Autoimmune disease triggered if T cells miss a single protein early on 2Autoimmune disease triggered if T cells miss a single protein early on 3
Product Information Request - U-0080D Diode Array Bio-Spectrophotometer from Hitachi High Technologies America
Product Information Request - SuperSignal West Pico COMPLETE Biotinylated Protein Detection Kit from Pierce Biotechnology, Inc.
AMV RT HC 600 U from Invitrogen
iTaq DNA Polymerase, 5,000 U from Bio-Rad
Biology Products: